HIV Science Geneva 2027 objectives
Quick links to other pages:
HIVR4P 2027 objectives
HIVR4P 2027, the 6th HIV Research for Prevention Conference, will bring the world's scientific community to the global health hub of Geneva, Switzerland, to explore the latest in the prevention science pipeline, including vaccines, bNAbs and delivery platforms.
This will take place across four thematic areas: factors influencing HIV transmission and prevention; means of HIV prevention; correlates of protection and vaccine development; and crossover topics, such as preclinical studies, STIs and mpox.
HIVR4P 2027 will focus on five key objectives:
Objective 1
Advance scientific discovery and collaboration in HIV and STI prevention by convening global experts and key and affected populations to share new findings.
Objective 2
Accelerate the development of HIV prevention technologies from basic science to clinical trials, focusing on bNAbs, vaccines and antiretroviral approaches.
Objective 3
Embed person-centred and community-led perspectives in basic and clinical prevention research so that new products and approaches reflect the needs, preferences and choices of the people who will use them.
Objective 4
Identify knowledge gaps and priorities to shape the future research agenda for basic and clinical HIV prevention.
Objective 5
Translate insights in basic and clinical research into clear priorities for policy makers and funders to sustain interest and investment in the generation and communication of HIV prevention science.
IAS 2027 objectives
IAS 2027, the 14th IAS Conference on HIV Science, will bring together scientists, programme implementers, policy makers and communities in Geneva to examine the latest advances in HIV science and assess progress in ensuring that effective HIV prevention and treatment tools reach everyone who needs them.
Against a changing epidemiological landscape and persistent gaps in prevention, treatment and care, the conference will foster critical dialogue, strengthen international collaboration, and identify evidence-based approaches that can be translated into policy and practice.
IAS 2027 will focus on five key objectives:
Objective 1
Accelerate basic and clinical sciences innovation to better understand pathogenesis, develop and translate antiviral and immune-based technologies for treatment, and advance the global HIV response towards a cure.
Objective 2
Drive the translation of evidence into impact through optimized delivery and scale-up strategies for effective biomedical, behavioural and structural approaches to HIV prevention, treatment and care by addressing implementation challenges and barriers to equitable access, individual uptake and system-wide adoption.
Objective 3
Advance interdisciplinary collaboration across the spectrum of person-centred HIV research to address whole-person health and improve HIV outcomes across the life course, with a focus on key and vulnerable populations, children and adolescents, women and people ageing with HIV.
Objective 4
Fast track integrated responses to HIV, including advanced disease, co-infections, co-morbidities and other public health challenges and emergencies to strengthen health system resilience and global preparedness and capacity to respond to emerging health threats.
Objective 5
Foster international scientific collaboration and leadership, with communities at the centre, to ensure that scientific research responds to the real needs and priorities of people living with HIV worldwide.